Facing COVID-19's Challenges to Care for the CaregiverSeptember 22nd 2020
When the coronavirus disease 2019 (COVID-19) pandemic prevented Christie M. Santure, BSN, RN, OCN, from hosting her caregiver support group, she quickly adapted and switched to a virtual format.
Trial To Evaluate Eprenetapopt-Azacytidine Combo in TP53+ MDS Completes EnrollmentJune 18th 2020
A phase 3 trial designed to evaluate eprenetapopt plus azacytidine (Vidaza) in patients with TP53-mutant positive myelodysplastic syndrome (MDS) completed full enrollment, according to Aprea Therapeutics, Inc.
Tivozanib Tolerability Shows Potential Advantage for Patients with Advanced RCCMay 20th 2020
Oncology Nursing News sat down with Brian Rini, MD, from the Vanderbilt-Ingram Cancer Center (VICC), to discuss results from the phase III TIVO03 trial, and its potential impact on patients with relapsed or refractory renal cell carcinoma.
Patient Education for Oral Therapies Is CrucialApril 29th 2020
There is far less patient education for oral agents, such as CDK4/6 inhibitors for breast cancer, as there is for chemotherapy. This is a major issue, explained Patricia Jakel, MN, RN, AOCN, advanced practice nurse at UCLA's solid tumor program and co-editor in chief of Oncology Nursing News.
Struggles in Full Biomarker Testing for Lung CancerApril 16th 2020
With minimally invasive procedures to test lung cancer tumors, there often isn't enough tissue to undergo a full biomarker test, pointing toward the strength of liquid biopsies, explained Lynette M. Sholl, MD, chief of thoracic pathology at Brigham and Women's Hospital, Dana-Farber Cancer Institute, and associate professor at Harvard Medical School.
Making Cold Breast Cancer Tumors HotMarch 24th 2020
There are multiple factors in making "cold" breast cancer tumors "hot," meaning that they respond to chemotherapy, explained Hope S. Rugo, MD, FASCO, director of Breast Oncology and Clinical Trials Education at the University of California San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center.
COVID-19 and Cancer: Oncologist Shares His ViewMarch 12th 2020
Aditya Bardia, MD, MPH, attending physician at Massachusetts General Hospital and assistant professor of medicine at Harvard Medical School, discusses COVID-19 (Coronavirus) risk in patients with cancer and the elderly.
Genetic Testing: Knowledge Is PowerMarch 10th 2020
Some patients with breast cancer might be apprehensive to undergo genetic testing, but it is crucial both for them and their family members. Lauren Carcas, MD, medical oncologist at the Miami Cancer Institute, discusses some main points nurses can make to these patients to encourage them to get tested.
What Defines Value-Based Cancer Care?March 5th 2020
Healthcare value has been defined as outcomes divided by costs, but it's not always that simple, especially in treating patients with cancer, explained Stuart L. Goldberg, MD, Chief, Division of Outcomes and Value-Based Care at the John Theurer Cancer Center and associate professor of medicine at Seton Hall School of Medicine.
EMRs Useful for Nurses Treating Patients With CAR T-Cell TherapyFebruary 27th 2020
Electronic medical records (EMRs) are crucial for nurses to track adverse events and other important information for patients undergoing CAR T-cell therapy, explained Andrea Price, APN, associate director for clinical research at Washington University School of Medicine.